For instance, the glutaminase inhibitors were effective in reducing the growth of SDH and FH-deficient cancers [227,228,229] by lowering the glutamine needed to replenish TCA intermediates [227,229] including the R-2HG in IDH mutant tumours [230,231,232]. Here, IDH2 is linked to neoplasm.